Publication detail

Liposomal Form of Erlotinib for the Inhalation Drug Delivery

SZABOVÁ, J. MIŠÍK, O. FUČÍK, J. MRÁZOVÁ, K. MRAVCOVÁ, L. KRZYZANEK, V. LÍZAL, F. MRAVEC, F.

Original Title

Liposomal Form of Erlotinib for the Inhalation Drug Delivery

Type

abstract

Language

English

Original Abstract

This contribution is focused on the encapsulation of erlotinib to liposomes with different properties which are suitable for inhalation drug delivery.

Keywords

Liposome, Inhalation, Erlotinib, Nebulization, Non-small cell lung cancer

Authors

SZABOVÁ, J.; MIŠÍK, O.; FUČÍK, J.; MRÁZOVÁ, K.; MRAVCOVÁ, L.; KRZYZANEK, V.; LÍZAL, F.; MRAVEC, F.

Released

20. 10. 2022

Publisher

Tanger Ltd.

Location

Ostrava, CZ

Pages from

89

Pages to

89

Pages count

1

BibTex

@misc{BUT179651,
  author="Jana {Szabová} and Ondrej {Mišík} and Jan {Fučík} and Kateřina {Mrázová} and Ludmila {Mravcová} and Vladislav {Krzyžánek} and František {Lízal} and Filip {Mravec}",
  title="Liposomal Form of Erlotinib for the Inhalation Drug Delivery",
  booktitle="Nanocon 2022 – Abstracts",
  year="2022",
  edition="1",
  pages="89--89",
  publisher="Tanger Ltd.",
  address="Ostrava, CZ",
  note="abstract"
}